Know What's Happening in Healthcare
Know What's Happening in Healthcare
Healthcare Pulse
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
Breakthrough Non‑Hormonal Male Pill Shows 95% Efficacy in Phase‑III Trials
A multinational research team announced a reversible, non‑hormonal male contraceptive pill that achieved 95% efficacy in Phase‑III trials. The compound was safe across a diverse cohort with no hormonal side effects, and participants regained normal fertility within three months after stopping treatment.
Also developing:
By the numbers: Gilead to acquire Tubulis for $5B
Imaging interpretation turnaround times for Medicare fee‑for‑service patients have more than doubled between 2014 and 2023, rising from roughly 2.2 hours to 4.6 hours on average. The slowdown is especially acute for advanced modalities, with CT scans experiencing a 318% increase and MRIs a 256% increase in delay. Researchers attribute the trend to a radiology workforce that is approaching its capacity, noting that lower‑income and disadvantaged communities face the longest waits. The findings were released in the Journal of the American College of Radiology and underscore growing pressure on imaging services.
The FDA released three new guidances under its Drug Competition Action Plan to streamline generic drug reviews. A final guidance clarifies the use of Information Requests and Discipline Review Letters, a revised draft updates procedures for aligning ANDA labeling with...
The FDA approved Sage Chemical’s generic apomorphine hydrochloride cartridges, the first generic version of Apokyn for treating "off" episodes in advanced Parkinson’s disease. The generic cartridges work only with the proprietary Apokyn Pen, which must be obtained separately through specialty...
The FDA revised Evusheld's Emergency Use Authorization on Jan. 26, 2023, limiting its use to situations where susceptible SARS‑CoV‑2 variants comprise 90% or less of national cases. With current CDC data showing over 90% of circulating variants are resistant, Evusheld...
The U.S. Food and Drug Administration revoked the Emergency Use Authorization for sotrovimab on April 5, 2022, after CDC data showed the Omicron BA.2 sub‑variant accounted for more than 50 % of cases in every HHS region. Earlier in the year the agency...
The FDA is hosting a virtual workshop on May 18, 2026 to advance novel surrogate endpoints for rare disease drug development. The event is part of the Rare Disease Endpoint Advancement (RDEA) Pilot Program, mandated by PDUFA VII and FDORA, which requires up...
The U.S. Food and Drug Administration issued warning letters to twelve companies for selling over‑the‑counter skin‑lightening products that contain hydroquinone, an ingredient not approved for OTC use. The agency highlighted serious adverse events such as rashes, facial swelling, and permanent...
As a medical school professor, I teach that the gut-brain axis is real. But even I was surprised by this. A review in Nutrition Research confirmed: reshaping the gut microbiome can enhance cognitive performance and slow dementia progression. Key findings across multiple...
Researchers at Irish universities have demonstrated that extracts from the wildflower tormentil (Potentilla erecta) possess strong antimicrobial activity against multidrug‑resistant bacteria, including strains that cause pneumonia and urinary‑tract infections. The study identified ellagic acid and agrimoniin as the key compounds...
Frazier Healthcare Partners has appointed Randy Hyun as an executive in residence, a role designed to scout and evaluate new investment opportunities. Hyun will concentrate specifically on the pharmacy services sector, leveraging his industry experience to identify high‑growth targets. The...
A phase 3 CANOPY subset analysis evaluated pemivibart, a recombinant IgG1 monoclonal antibody, for pre‑exposure COVID‑19 prophylaxis in patients with chronic lymphocytic leukemia (CLL). Among 29 CLL participants, none developed symptomatic SARS‑CoV‑2 infection over a 180‑day follow‑up, and the safety profile...
A UCLA-led study published in JAMA Network Open finds that unionized direct care workers (DCWs) experience significantly lower turnover than their non‑unionized peers, cutting overall attrition from 45% to 37%. The reduction spans nonprofit, for‑profit, and public sectors, translating into...
A systematic review of eight studies suggests that post‑transplant gilteritinib maintenance may markedly improve survival for patients with relapsed or refractory FLT3‑mutated acute myeloid leukemia. One‑year overall survival rates ranged from 72.3% to 100%, while two‑year overall survival hovered around...
Precision BioSciences (NASDAQ: DTIL) announced it will present at the 25th Annual Needham Virtual Healthcare Conference on April 14, 2026 at 9:30 am ET. The virtual session will showcase the company’s ARCUS® gene‑editing platform and its in‑vivo therapeutic pipeline, including programs...
A new U.S. study of over four million cancer cases finds adults who have never married face a markedly higher risk of developing cancer than those who are or have been married. The elevated risk spans most major cancer types,...
Bausch + Lomb received FDA 510(k) clearance for its Bi‑Blade™+ dual‑port vitrectomy cutter and the Adaptive Fluidics update on the Stellaris Elite system. The new cutter operates at 25,000 cuts per minute, a 66% speed boost over the prior model, and delivers a...
Americhem announced a new clean‑compounding facility in Suzhou, China, slated for the second half of 2026. The plant will be built to ISO 13485 and cGMP standards, extending the company’s regulated healthcare polymer network into Asia. At Chinaplas 2026 the firm will...
A new microsimulation study published in the Journal of Medical Economics finds that three rounds of next‑generation multitarget stool DNA (mt‑sDNA) testing over ten years outperform a single colonoscopy in real‑world colorectal cancer (CRC) screening. Higher patient adherence—72% versus 38%...
Google announced today that its Gemini chatbot will now display a one‑touch crisis‑help card and a redesigned “Help is available” module when users show signs of distress. The company also committed $30 million over three years through Google.org to expand crisis‑helpline...
Scientists reported that psychedelics temporarily loosen self‑related brain networks, enabling the first detailed mapping of how the brain constructs the sense of self. The finding, highlighted by The Hindu, could reshape spirituality research and therapeutic approaches to mental health.
A randomized pilot study of 60 multiple sclerosis patients showed that a 12‑week Wim Hof Method program significantly reduced blood inflammatory markers, matching the effect of a structured lifestyle intervention. Researchers say the findings support the method as a safe...
Researchers analyzing data from over 470,000 adults report that a higher proportion of vigorous physical activity—more than 4% of total exercise—reduces the risk of eight chronic diseases by 29% to 61% compared with no vigorous activity. The findings, published online...
Life Biosciences, the Boston biotech co‑founded by David Sinclair, announced that its partial cellular reprogramming therapy will enter a first‑in‑human trial in 2026. The study will enroll 18 participants with glaucoma or non‑arteritic anterior ischemic optic neuropathy (NAION) and will...
My eye doctor gave me a cardiovascular risk score from my retinal scan. New data from ACC.26: an AI system analyzing routine eye exam images identified elevated heart disease risk with 91% sensitivity. Matched the standard cardiologist risk calculator. One in...
A recent analysis of 2016‑2023 Optum claims data shows that asthma patients who switched from a medium‑dose inhaled corticosteroid (ICS) directly to a biologic experienced markedly larger reductions in exacerbations and systemic corticosteroid fills than those who escalated to high‑dose ICS....
The UK Department of Health and Social Care has awarded a £1.25 million (≈ $1.59 million) contract to Marvell Consulting to build a public‑beta "Find Public Health Data" service that will replace the aging Fingertips platform. Hosted on Microsoft Azure, the new service...
Choking ranks as the fourth leading cause of unintentional injury death worldwide, and survival hinges on actions taken in the first minutes. The article outlines the distinct signs of partial versus complete airway obstruction and stresses the five‑and‑five cycle of...
Modern aesthetic medicine has shifted from surgery‑centric procedures to a rapidly expanding suite of non‑invasive, device‑based technologies that target skin health at a structural level. Energy‑based platforms such as radiofrequency, high‑intensity focused ultrasound, lasers and light devices now dominate clinical...
NHS Grampian has mapped out twelve digital priority programmes for 2026/27, spanning the MyCare.scot front‑door portal, a national child health record, Microsoft 365, Windows 10 replacement, PACS and RIS imaging platforms, INFIX theatre scheduling, LIMS, GP IT and core infrastructure upgrades....
Gloucestershire Royal Hospital has installed Canon Medical’s Alphenix Core+ angiography X‑ray system to expand its cardiac pacing services. The new system supports around 700 pacemaker implantations, 300 rhythm procedures and 2,000 angiograms annually, while offering ultra‑low radiation and AI‑driven image...
The Scottish Ambulance Service piloted a new volunteer responder app across 46 Community First Responder schemes from November 2025 to February 2026. The trial delivered a 36% increase in volunteer incident responses, equating to 786 more patients assisted, and saw...
The Welsh Government has completed the rollout of the OpenEyes electronic patient record and OPERAi electronic referral systems across all health boards, enabling real‑time clinical data sharing and standardized referral pathways. Glaucoma modules are now live in several boards, with...
The menopause market has surged to roughly $17 billion, driven by celebrity awareness and telehealth startups, yet scientific backing lags behind demand. Only about 6 % of private healthcare funding is allocated to women’s health, leaving many treatments unproven and clinical guidance...
Despite rapid advances in adult medical technology, pediatric devices remain scarce. A recent review shows only 0.5% of FDA‑approved orthopaedic devices and 2% of AI radiology tools are labelled for children, while the UK spends just 5% of its health...
At Cedars‑Sinai’s virtual medical conference, Dr. Brennan Spiegel introduced the “blended intelligence” model, arguing that AI should augment—not replace—physicians. He highlighted smart‑glass heads‑up displays that stream real‑time electronic health record data into the exam room, and VR‑AI simulations designed to...
Portugal’s healthtech and medtech ecosystem has moved from a niche academic cluster to a mature, export‑driven sector, with over 4,700 active ventures and a 16 % growth rate. Venture capital surged to €886 million ($965 million) in 2024, fueling deep‑tech leaders in AI‑driven...
Researchers announced a new class of orexin‑mimicking agents that directly address the neuropeptide deficiency underlying Type 1 narcolepsy. Highlighted in Nature Biotechnology, the drugs aim to replace missing orexin signaling, offering a potential disease‑modifying alternative to stimulant‑based symptom control.
Castle Rock Hormone Health (CRHH) has launched an elite longevity program that blends hormone optimization, peptide therapy, cold‑plunge recovery and advanced monitoring for elite athletes, executives and creators. The clinic says the data‑driven regimen is designed to restore physiological balance...
Novo Nordisk introduced Wegovy HD, a high‑dose GLP‑1 injection priced at $399 per month, $50 less than Eli Lilly’s Zepbound at $449. The new 7.2 mg dose triples the previous 2.4 mg maximum, aiming to boost weight‑loss efficacy. Novo’s shares jumped 2.7% following...
Bangladesh is confronting a deadly measles outbreak that has claimed more than 100 children’s lives, most of them under nine months old. The government, together with UNICEF, has launched an emergency measles‑rubella vaccination drive targeting millions of children, aiming to...
Holivita’s AI-driven platform, dubbed “Our Bodies Speak a Language,” combines foundational biological data with large‑scale clinical records to uncover hidden health patterns. Scientist Dmitry Chebanov says the system could shift medicine from reactive treatment to proactive prevention, especially in aging...
Blackstone and TPG have installed José “Joe” Almeida, former Baxter International CEO, as chief executive of Hologic after completing an $18 billion buyout. The leadership change follows the private‑equity deal that valued Hologic at up to $79 per share and assumed...
Researchers in Michael Mitchell’s lab at the University of Pennsylvania have engineered lipid nanoparticles that simultaneously carry mRNA and a linked drug, creating a combined immunotherapy platform for solid tumors. The new prodrug‑tethered LNPs aim to activate immune cells while...
Sitting a lot isn’t equally harmful for everyone. In this meta-analysis of >1 million adults, people who sat >8 h/day had no increased mortality risk if they also did about 60–75 min/day of moderate physical activity. (35.5 MET h/week). People doing...
Evotec SE reported a 103% rise in Q4 adjusted EBITDA to €58 million and a 14% revenue increase, driven by a €65 million Sandoz license payment. At the same time, activist investor MAK Capital is urging the firm to spin off its...
NYC Health + Hospitals CEO Mitchell H. Katz announced the system is ready to replace many radiologists with AI once regulatory hurdles are cleared. He cited AI’s ability to interpret mammograms and X‑rays, promising lower labor costs and expanded screening...
Nurix Therapeutics reported Q1 2026 results, highlighting ongoing enrollment in the Phase 2 DAYBreak CLL‑201 trial and plans to launch a global Phase 3 DAYBreak CLL‑306 confirmatory study by mid‑year. The company also advanced a new tablet formulation of bexobrutideg to support an...
What are NSAIDs? https://t.co/GPV7DlHNyD People often take NSAIDs, such as ibuprofen, to manage pain. In this blog, we explore the mechanisms of action of NSAIDs. We also explore how the mechanism may have important implications for athletes. https://t.co/5QGp4HCMTp
Hemispherian AS announced the initiation of a first‑in‑human Phase 1/2a trial of GLIX1 in patients with recurrent glioblastoma and other high‑grade gliomas. GLIX1 is an oral, first‑in‑class small‑molecule TET2 activator that induces tumor‑selective DNA damage and has demonstrated potent preclinical efficacy,...
Healthcare Management Administrators (HMA) marked its 40th anniversary as a leading third‑party administrator for self‑funded employers. Founded in 1986, the firm emphasizes a people‑first culture, unbundled solutions, and deep broker partnerships. HMA reports medical and pharmacy cost trends consistently below...
